Sep. 7 at 6:59 PM
Main Watchlist Mon Sept 8th
$NUVB FDA + China approval, NCCN guideline, and fresh WCLC data. Price is coiling under 4 with 32.9% short float lined up for a squeeze
$ACRV FDA breakthrough designation confirmed, trading under cash value, only 11.8M float that rotated 20x on Friday
$UUU Declared a
$1 special dividend with Sept 26 ex-date. Ultra-low 1.8M float makes this one explosive
$GELS Announced a preclinical antihistamine trial. Float is 5.4M with 60% insider lock and Friday rotated it 13x
$TNFA Nano float 1.8M with reported 291% short interest. Crypto license plus biotech trial gives it dual catalyst power
These 5 have the strongest catalysts, tight supply, and breakout setups heading into premarket tomorrow